A role as inhibitor of NK effector functions has been recently described also for IDO1, a rate-limiting metabolic enzyme that converts tryptophan into downstream catabolites kynurenines (KYN) (99) and is involved in the establishment and maintenance of peripheral tolerance and tumor immune escape (33). Here, IDO1 is linked to neoplasm.